Proveris News
Hudson, MA, October 9, 2018 – Proveris Scientific Corporation, a leading provider of services and technology to advance the science of aerosol and spray products, today announced that it has achieved certification status under international quality standard, ISO 9001:2015. This is a major accomplishment for the organization, having transitioned from the previous 2008 edition of […]
Hudson, MA, August 10, 2018 – Proveris Scientific Corporation, a leading provider of services and technology to advance the science of aerosol and spray products, today announced the appointment of experienced life sciences professional John Masciola, as Vice President of Product Development. “We are very excited to have John on the Proveris team” said Chip […]
Impact of Actuator Design on Multi Dose Nasal Spray Characteristics. Authors: Heli Chauhan, Shau Neen Liu-Cordero, Lingzhi Liao, and Joseph Werbeck Proveris Scientific Corporation Developing a successful multi-dose nasal spray can be a difficult process. A number of components and critical parameters need to be precisely controlled to achieve desired dose delivery. Numerous studies have […]
Marlborough, MA, March 27, 2018 – Proveris Scientific Corporation announces its participation in RDD (Respiratory Drug Delivery), a leading conference focusing on the development and commercialization of pulmonary and nasal pharmaceutical products. This five-day event will be held 22-26 April, 2018 at JW Marriott Starr Pass Resort & Spa Tucson, Arizona. Attendees at the conference […]
Marlborough, MA, February 27, 2018–Proveris Scientific announced today the spin-off of real-time, inhaler-specific voice guidance technology to Uneva Health, Inc. The technology is the core of a device/digital health platform Uneva Health is developing to reduce the enormous annual costs of inconsistent dosing caused by improper inhaler use while improving patient engagement and compliance. The platform […]
Marlborough, MA, February 1, 2018 – Proveris Scientific Corporation today announced Chip Leveille has been named President, effective immediately. As President, Leveille will have responsibility for all areas of corporate operations including Sales, Marketing, Business Development, Support, Product Development, Quality, Operations, Finance and Human Resources. He will report directly to Chief Executive Officer Dino Farina. […]
Marlborough, MA, April 19, 2016 – Proveris Scientific Corporation announced today that the Company’s SprayVIEW® measurement system was used by Summit Biosciences during development of the first generic unit dose nasal spray product approved by the FDA. Approval of the abbreviated new drug application (ANDA) for Sumatriptan nasal spray USP, 5 mg and 20 mg […]
DPT will be presenting a poster, co-authored with Proveris Scientific, at the RDD 2016 in Scottsdale, Arizona. This event will take place from April 17th through the 21st, 2016. Proveris will also host an Exhibition Table (#63) and encourage attendees to stop by and learn about our products and services, including our new Viota® Software Unit Dose Module.
Proveris’ CEO, Dino Farina, will be presenting a poster (Poster #65) titled “Understanding the importance and effects of shaking on pMDI performance“. The Drug Delivery to the Lungs Conference will be held from December 9th through the 11th, 2015 at the Edinburgh International Conference Centre, Edinburgh, Scotland, UK. Please visit our DDL26 page to learn more about our involvement as a […]
Proveris Scientific is proud to introduce the new Viota® Software Module for Unit Dose nasal spray testing. Please visit our new products page to learn more and to request additional product information!
